India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

IJ advised on Beyond Renewables’ pre-seed funding round

IJ advised Investor in Reia pre-seed funding

IJ advised the Investor in VAMA’s INR 22 Crore Pre-Series A funding round.

Publications

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

AML Issues & Compliances By Entities In GIFT City

Newsletters

Recent Competition Law Updates

REGULATING THE FUTURE: INDIA’S HESITANT PATH VS. THE UK’S PRAGMATIC BLUEPRINT FOR CRYPTO MARKETS

Indian Banks and Russian Oil: How Sanctions are Reshaping India’s Energy Trade